Almac Group announce record revenue figure with 1800 new roles created in global expansion programme

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has today announced its financial results for year ending September 30, 2023. Figures released show the company recorded a £118 million (14%) rise in revenue, up from £840 million in 2022 to £958 million in the period.  Operating profit rose again – final pre-tax profits

Continue Reading